• OccamsRazer@lemmy.world
        link
        fedilink
        arrow-up
        1
        ·
        1 day ago

        Better than I expected, tbh, but these aren’t very compelling conclusions. There are several major weaknesses in the study, and it’s only one among many that reached different conclusions. They acknowledge all of this and conclude that more study is needed. What i get from it is that there might be (may have been) some detriment to society from covid, and vaccines could possibly reduce that detriment slightly. With the benefit being pretty weak at this point in the trajectory of covid, it’s not surprising that the fda isn’t renewing the emergency use approval. It certainly doesn’t warrant the hand wringing from the guy I originally responded to.

        • Bytemeister@lemmy.world
          link
          fedilink
          English
          arrow-up
          1
          ·
          1 day ago

          They was just one example.

          Let’s not forget that we are using hospital resources for Covid patients which would otherwise be available or not required at all. There is a social cost there.

          When people are sick with Covid, it affects their economic productivity. Not that we should really care, but sick workers make less money for the billionaires.

          The journal is one peer reviewed source that shows there is congnitive decline that correlates strongly with the severity of a Covid infection. Reducing the number of infections, and reducing the severity (both things vaccines can do very well) reducing the collective cognitive impact to the population and the knock-on effects of those cognitive issues.

          • OccamsRazer@lemmy.world
            link
            fedilink
            arrow-up
            1
            ·
            1 day ago

            The journal article also shows that the affect diminished over time, presumably because the covid variant reduced in severity compared to early versions. This reduces the affect on the population and reduces the need for a vaccine. Especially a vaccine meant for a group that was never high risk to begin with.